Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Significant Accounting Policies (Details)

v3.22.1
Nature of Business and Significant Accounting Policies (Details)
 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 24, 2021
USD ($)
Jun. 14, 2021
USD ($)
Oct. 31, 2018
USD ($)
Jun. 27, 2018
USD ($)
shares
Feb. 28, 2018
USD ($)
Dec. 04, 2017
USD ($)
Apr. 29, 2015
shares
Dec. 10, 2014
shares
Nov. 12, 2014
shares
Feb. 28, 2022
USD ($)
Feb. 28, 2021
USD ($)
Feb. 28, 2022
USD ($)
shares
Feb. 28, 2021
USD ($)
shares
May 31, 2021
USD ($)
May 31, 2020
USD ($)
Jan. 04, 2022
USD ($)
Apr. 30, 2021
USD ($)
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Equity Method Investment, Ownership Percentage                 55.60% 50.00%   50.00%          
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares               6,250,000                  
Stockholders' Equity Note, Stock Split, Conversion Ratio               0.625                  
Debt Instrument, Face Amount                               $ 2,500,000 $ 6,229,672
Asset Impairment Charges                   $ 0 $ 2,498,706 $ 0 $ 2,498,706 $ 2,498,706      
Financing Receivable, after Allowance for Credit Loss, Current   $ 3,000,000 $ 5,000,000                            
Proceeds from Collection of Notes Receivable                       2,218,574 1,544,291        
Cash and Cash Equivalents, at Carrying Value                   3,454,584   3,454,584   1,665,263 $ 2,925,568    
Accounts Receivable, Credit Loss Expense (Reversal)                   2,329 0 2,329 5,927        
Goodwill       $ 25,742,899           557,896   557,896   557,896 557,896    
Advertising Expense                   299,154 383,128 1,087,692 826,867        
Research and Development Expense                   1,800 $ 8,334 $ 12,308 $ 20,726        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                       76,251,384 87,861,815        
Goodwill, Impairment Loss                           25,185,003 25,185,003    
Warrant [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                       7,346,297 54,410,145        
Equity Unit Purchase Agreements [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                       3,041,290 7,676,974        
Convertible Debt Securities [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                       65,693,797 25,454,696        
Stock Payable [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                       170,000 320,000        
Kealii Okamalu, LLC [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Equity Method Investment, Ownership Percentage 50.00%                                
Payments to Acquire Interest in Joint Venture                       $ 100,000          
Kealii Okamalu, LLC [Member] | Maximum [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Interest in Joint Venture $ 3,000,000                                
Shares of CLS Holdings USA, Inc. [Member] | CLS Labs, Inc. [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares                 10,000,000                
Investor [Member] | Kealii Okamalu, LLC [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Interest in Joint Venture                       0          
Principal [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Asset Impairment Charges                           2,497,884      
Accrued Interest [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Asset Impairment Charges                           822      
Reverse Merger with CLS Labs [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Stock Issued During Period, Shares, New Issues (in Shares) | shares             15,000,000                    
Oasis Acquisition [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Businesses, Gross         $ 6,200,000                        
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions         10.00%                        
Liabilities Assumed         $ 204,457                        
Oasis Acquisition [Member] | Oasis LLCs [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners       90.00%                          
Oasis Acquisition [Member] | Oasis LLCs [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Businesses, Gross       $ 5,995,543                          
Debt Instrument, Face Amount       $ 4,000,000                          
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares       22,058,823                          
Oasis Acquisition [Member] | Deposit [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Businesses, Gross           $ 250,000                      
Oasis Acquisition [Member] | Additional Payments [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Businesses, Gross           $ 1,800,000                      
In Good Health [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Payments to Acquire Businesses, Gross     35,000,000                            
Business Combination, Consideration Transferred     47,500,000                            
Business Combination, Consideration Transferred, Liabilities Incurred     7,500,000                            
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned     5,000,000                            
Business Combination, Contingent Consideration, Liability     $ 2,500,000                            
Debt Instrument, Interest Rate, Stated Percentage     6.00%                            
Interest Rate, Default     15.00%                            
Financing Receivable, after Allowance for Credit Loss, Current                   $ 833,333   833,333          
Proceeds from Collection of Notes Receivable                       2,218,572   $ 1,696,765 $ 1,425,000    
In Good Health [Member] | Principal [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Proceeds from Collection of Notes Receivable                       2,166,667          
In Good Health [Member] | Accrued Interest [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Proceeds from Collection of Notes Receivable                       $ 51,905          
In Good Health [Member] | Due And Payable On Or Before June 21, 2021 [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Proceeds from Collection of Notes Receivable   500,000                              
In Good Health [Member] | Due And Payable On Or Before July 12, 2021 [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Proceeds from Collection of Notes Receivable   500,000                              
In Good Health [Member] | Due And Payable In12 Monthly Installments [Member]                                  
Nature of Business and Significant Accounting Policies (Details) [Line Items]                                  
Proceeds from Collection of Notes Receivable   $ 2,000,000